Femoral Arterial Cannulation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00486096|
Recruitment Status : Terminated (sufficient data collected.)
First Posted : June 13, 2007
Last Update Posted : March 16, 2012
Many children undergoing surgery for congenital heart disease have had prior operations. Re-operative sternotomy carries with it the risk of cardiac injury and the need for emergent peripheral cannulation.
Our first aim is to demonstrate that peripheral arterial cannulation may be lifesaving in cases of complicated sternal re-entry in children and that angio-catheters can be utilized when vessels are too small for standard cannulas.
Our secondary aim is to present a case report of successful femoral cannulation in a 5 kg child.
|Condition or disease|
In children, many of the standard operative sites are either occluded, stenosed, or too small for the smallest manufactured cannulas. In these instances, it may be feasible to utilize angio-catheters for arterial access until central cannulation can be achieved safely. In an in vitro model, we have simulated a cardiopulmonary bypass circuit and arterial cannulation with angio-catheters.
It appears that angio-catheters may be used with acceptable flow hemodynamics for blood vessels too small for standard cannulas.
We have performed this successfully in a 5 kg child.
We have completed the cardiopulmonary bypass model and are ready to submit the hemodynamic data. We would like to submit to a national meeting and hopefully for publication thereafter.
|Study Type :||Observational|
|Actual Enrollment :||1 participants|
|Official Title:||Femoral Arterial Cannulation in Infants Following Complicated Sternal Re-entry|
|Study Start Date :||February 2007|
|Actual Study Completion Date :||August 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00486096
|United States, Georgia|
|Children's Healthcare of Atlanta|
|Atlanta, Georgia, United States, 30329|
|Principal Investigator:||Brian E Kogon, MD||Emory Univ. / Children's Healthcare of Atlanta|